Skip to main content
. Author manuscript; available in PMC: 2014 May 13.
Published in final edited form as: Leukemia. 2014 Jan 10;28(5):1167–1170. doi: 10.1038/leu.2014.14

Figure 1. Expression of proposed leukemia associated antigens in acute myeloid leukemia (AML) patient samples and healthy tissues.

Figure 1

A) No single antigen was expressed in all cases of AML and many proposed antigen candidates are not frequently overexpressed in AML. PB=Peripheral Blood. BM=Bone Marrow. Fold change overexpression (OE) compared to median expression in healthy donors where light red indicates OE of 5–50x, red indicates OE of 50–500x, bright red indicates OE >500x. Black indicates no detectable expression; white indicates expression values seen in similar range as healthy donors. First thirty AML samples listed were from PB and are therefore compared to healthy donor PB, remaining 18 are from BM and compared to expression in healthy donor BM. B) Antigen expression in various human tissue types. Compared to median expression in healthy donors using same heat-map schema same as above.